NYSE:BDXMedical Equipment
Did BD’s All‑in‑One CVC Launch Just Shift Becton Dickinson’s (BDX) Investment Narrative?
In April 2026, Becton Dickinson commercially launched the BD CentroVena One Insertion System in the U.S., the first all‑in‑one central venous catheter insertion device cleared under the FDA’s 510(k) pathway and accepted into the Safer Technologies Program.
The launch marks BD’s entry into the acute CVC market, potentially reshaping workflows and safety practices in high‑pressure acute care settings by consolidating multiple components into a single platform.
We’ll now examine how BD’s entry...